Connection between sleep cycle and cancer incidence
the ONA take:
A study by Virginia Tech biologists found that the benefits of a good night’s sleep include preventing cancer. These findings are likely to provide insight into the influence of the body’s internal clock on cancer development.
The researchers found that the protein human period 2 is responsible for regulating the body’s sleep cycle, or circadian rhythm. It also protects the body from developing sporadic forms of cancer. Unaltered, the human period 2 protein interacts with tumor suppressor proteins in cells to control cell division.
When environmental factors are altered, including sleep cycle disruption, the function of the protein is impaired. The connection between the protein, circadian rhythm, and cancer development was observed by studying various human and animal tumor cells.
The researchers found that repressing the human period 2 gene led to abnormal circadian rhythmicity and a malignant transformation. Researchers have long studied the connection between circadian rhythms and cancer development, particularly breast cancer, in women who work night shifts such as nurses and flight attendants.
Researchers are now working closely with patients to identify those who may be at risk for cancer due to the malfunction of the human period 2 protein and the gene that produces it.
Benefits of a good night’s sleep include preventing cancer.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Pediatric Hepatocellular Carcinoma: Challenges and Solutions
- Earlier and Later Adult BMI Associated With Multiple Myeloma Risk
- Cost-Effectiveness of Immunotherapy for Advanced Melanoma Evaluated
- VBPWPs Can Compliment Patient Management in Clinical Trials
- Communication Technology Improves Treatment Burden, Patient Perspective of Oncology Care
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|